HEADER VIRAL PROTEIN/IMMUNE SYSTEM 26-MAR-23 8IV4 TITLE CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH DOUBLE TITLE 2 NABS 8H12 AND 3E2 (LOCAL REFINEMENT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIGHT CHAIN OF 3E2; COMPND 3 CHAIN: L; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: HEAVY CHAIN OF 3E2; COMPND 6 CHAIN: H; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: LIGHT CHAIN OF 8H12; COMPND 9 CHAIN: B; COMPND 10 MOL_ID: 4; COMPND 11 MOLECULE: HEAVY CHAIN OF 8H12; COMPND 12 CHAIN: A; COMPND 13 MOL_ID: 5; COMPND 14 MOLECULE: SPIKE PROTEIN S1; COMPND 15 CHAIN: G; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 6 ORGANISM_TAXID: 10090; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_TAXID: 10090; SOURCE 10 MOL_ID: 4; SOURCE 11 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 MOL_ID: 5; SOURCE 14 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 15 2; SOURCE 16 ORGANISM_TAXID: 2697049; SOURCE 17 GENE: S, 2; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F KEYWDS SARS-COV-2, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, VIRAL KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR H.SUN,Y.JIANG,Q.ZHENG,S.LI,N.XIA REVDAT 2 14-FEB-24 8IV4 1 JRNL REVDAT 1 16-AUG-23 8IV4 0 JRNL AUTH H.SUN,T.DENG,Y.ZHANG,Y.LIN,Y.JIANG,Y.JIANG,Y.HUANG,S.SONG, JRNL AUTH 2 L.CUI,T.LI,H.XIONG,M.LAN,L.LIU,Y.LI,Q.FANG,K.YU,W.JIANG, JRNL AUTH 3 L.ZHOU,Y.QUE,T.ZHANG,Q.YUAN,T.CHENG,Z.ZHANG,H.YU,J.ZHANG, JRNL AUTH 4 W.LUO,S.LI,Q.ZHENG,Y.GU,N.XIA JRNL TITL TWO ANTIBODIES SHOW BROAD, SYNERGISTIC NEUTRALIZATION JRNL TITL 2 AGAINST SARS-COV-2 VARIANTS BY INDUCING CONFORMATIONAL JRNL TITL 3 CHANGE WITHIN THE RBD. JRNL REF PROTEIN CELL V. 15 121 2024 JRNL REFN ESSN 1674-8018 JRNL PMID 37470320 JRNL DOI 10.1093/PROCEL/PWAD040 REMARK 2 REMARK 2 RESOLUTION. 3.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.590 REMARK 3 NUMBER OF PARTICLES : 217835 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8IV4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300036548. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SARS-COV-2 REMARK 245 SPIKE PROTEIN IN COMPLEX WITH REMARK 245 DOUBLE NABS 3E2 AND 1C4; SARS- REMARK 245 COV-2 SPIKE PROTEIN; NABS 8H12 REMARK 245 AND 3E2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TECNAI F30 REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2400.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, B, A, G, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 119 REMARK 465 GLU G 324 REMARK 465 SER G 325 REMARK 465 ILE G 326 REMARK 465 VAL G 327 REMARK 465 ARG G 328 REMARK 465 PHE G 329 REMARK 465 PRO G 330 REMARK 465 ASN G 331 REMARK 465 ILE G 332 REMARK 465 PRO G 527 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO L 8 -159.60 -85.52 REMARK 500 THR L 50 -8.43 69.30 REMARK 500 SER L 51 -5.79 -140.47 REMARK 500 SER L 92 -32.99 -131.26 REMARK 500 TRP L 93 -7.21 66.77 REMARK 500 SER H 7 -169.72 -161.15 REMARK 500 PRO H 41 1.85 -68.70 REMARK 500 SER H 120 -167.92 -162.30 REMARK 500 ALA B 51 -8.52 69.52 REMARK 500 HIS B 55 -169.51 -78.48 REMARK 500 PRO B 95 76.74 -68.71 REMARK 500 ARG A 89 -168.16 -127.05 REMARK 500 PHE G 342 -61.09 -100.18 REMARK 500 ASN G 343 56.52 -99.13 REMARK 500 LYS G 386 32.59 -97.17 REMARK 500 ASP G 389 49.53 -93.85 REMARK 500 ASP G 427 46.77 -91.97 REMARK 500 ASP G 428 29.19 -142.14 REMARK 500 TYR G 449 33.26 -99.60 REMARK 500 TYR G 473 -14.11 74.45 REMARK 500 PHE G 486 -158.04 -86.89 REMARK 500 CYS G 488 66.98 72.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN G 487 CYS G 488 -131.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-35740 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH REMARK 900 DOUBLE NABS 8H12 AND 3E2 (LOCAL REFINEMENT) DBREF 8IV4 L 1 104 PDB 8IV4 8IV4 1 104 DBREF 8IV4 H 1 121 PDB 8IV4 8IV4 1 121 DBREF 8IV4 B 1 107 PDB 8IV4 8IV4 1 107 DBREF 8IV4 A 1 119 PDB 8IV4 8IV4 1 119 DBREF 8IV4 G 324 527 UNP P0DTC2 SPIKE_SARS2 324 527 SEQRES 1 L 104 GLN ILE VAL LEU THR GLN SER PRO ALA ILE MET SER ALA SEQRES 2 L 104 SER LEU GLY GLU GLU ILE THR LEU THR CYS SER VAL SER SEQRES 3 L 104 SER SER VAL SER ASP MET HIS TRP TYR GLN GLN LYS SER SEQRES 4 L 104 GLY THR SER PRO LYS VAL PHE ILE TYR SER THR SER ASN SEQRES 5 L 104 LEU ALA SER GLY VAL PRO SER ARG PHE SER GLY SER GLY SEQRES 6 L 104 SER GLY THR PHE TYR SER LEU THR ILE SER SER VAL GLU SEQRES 7 L 104 ALA GLU ASP ALA ALA TYR TYR TYR CYS HIS GLN TRP SER SEQRES 8 L 104 SER TRP THR PHE GLY GLY GLY THR LYS LEU GLU ILE LYS SEQRES 1 H 121 GLU VAL MET LEU VAL GLU SER GLY GLY GLY VAL VAL LYS SEQRES 2 H 121 PRO GLY GLY SER LEU LYS LEU SER CYS ALA ALA SER GLY SEQRES 3 H 121 PHE SER PHE SER THR TYR ALA MET SER TRP ILE ARG GLN SEQRES 4 H 121 THR PRO GLU LYS SER LEU GLU TRP VAL ALA ALA ILE SER SEQRES 5 H 121 SER GLY GLY THR ASN THR TYR TYR PRO GLY SER VAL LYS SEQRES 6 H 121 GLY ARG PHE THR ILE SER ARG ASP LYS ALA MET ASN THR SEQRES 7 H 121 LEU TYR LEU GLN LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 121 ALA MET TYR TYR CYS VAL ARG HIS SER GLY ASN TYR VAL SEQRES 9 H 121 ASP SER VAL MET ASP TYR TRP GLY GLN GLY THR SER VAL SEQRES 10 H 121 THR VAL SER SER SEQRES 1 B 107 ASP ILE VAL MET THR GLN PHE GLN LYS PHE MET SER THR SEQRES 2 B 107 SER VAL GLY ASP ARG VAL SER ILE THR CYS LYS ALA SER SEQRES 3 B 107 GLN ASN VAL ARG THR ALA VAL ALA TRP TYR GLN GLN LYS SEQRES 4 B 107 PRO GLY GLN SER PRO LYS ALA MET ILE TYR LEU ALA SER SEQRES 5 B 107 ASN ARG HIS ARG GLY VAL PRO ASP ARG PHE THR GLY SER SEQRES 6 B 107 GLY CYS GLY THR ASP PHE THR LEU THR ILE SER ASN VAL SEQRES 7 B 107 GLN CYS GLU ASP LEU ALA ASP TYR PHE CYS LEU GLN HIS SEQRES 8 B 107 ARG ASN TYR PRO LEU THR PHE GLY GLY GLY THR LYS LEU SEQRES 9 B 107 GLU ILE LYS SEQRES 1 A 119 GLU VAL LYS LEU GLU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 A 119 PRO GLY GLY SER MET LYS LEU SER CYS ALA ALA SER GLY SEQRES 3 A 119 PHE THR PHE SER ASP ALA TRP MET ASP TRP VAL ARG GLN SEQRES 4 A 119 SER PRO GLU LYS GLY LEU GLU TRP VAL ALA GLN ILE ARG SEQRES 5 A 119 ARG LYS ALA ASN ASN HIS ALA THR TYR TYR ALA GLU SER SEQRES 6 A 119 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASP SER LYS SEQRES 7 A 119 SER SER VAL TYR LEU GLN MET ASN SER LEU ARG ALA GLU SEQRES 8 A 119 ASP THR GLY ILE TYR TYR CYS ILE ARG GLY MET THR TYR SEQRES 9 A 119 ALA MET ASP PHE TRP GLY GLN GLY THR SER VAL THR VAL SEQRES 10 A 119 SER SER SEQRES 1 G 204 GLU SER ILE VAL ARG PHE PRO ASN ILE THR ASN LEU CYS SEQRES 2 G 204 PRO PHE GLY GLU VAL PHE ASN ALA THR ARG PHE ALA SER SEQRES 3 G 204 VAL TYR ALA TRP ASN ARG LYS ARG ILE SER ASN CYS VAL SEQRES 4 G 204 ALA ASP TYR SER VAL LEU TYR ASN SER ALA SER PHE SER SEQRES 5 G 204 THR PHE LYS CYS TYR GLY VAL SER PRO THR LYS LEU ASN SEQRES 6 G 204 ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SER PHE VAL SEQRES 7 G 204 ILE ARG GLY ASP GLU VAL ARG GLN ILE ALA PRO GLY GLN SEQRES 8 G 204 THR GLY LYS ILE ALA ASP TYR ASN TYR LYS LEU PRO ASP SEQRES 9 G 204 ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SER ASN ASN SEQRES 10 G 204 LEU ASP SER LYS VAL GLY GLY ASN TYR ASN TYR LEU TYR SEQRES 11 G 204 ARG LEU PHE ARG LYS SER ASN LEU LYS PRO PHE GLU ARG SEQRES 12 G 204 ASP ILE SER THR GLU ILE TYR GLN ALA GLY SER THR PRO SEQRES 13 G 204 CYS ASN GLY VAL GLU GLY PHE ASN CYS TYR PHE PRO LEU SEQRES 14 G 204 GLN SER TYR GLY PHE GLN PRO THR ASN GLY VAL GLY TYR SEQRES 15 G 204 GLN PRO TYR ARG VAL VAL VAL LEU SER PHE GLU LEU LEU SEQRES 16 G 204 HIS ALA PRO ALA THR VAL CYS GLY PRO HET NAG C 1 14 HET NAG C 2 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG 2(C8 H15 N O6) HELIX 1 AA1 SER H 28 TYR H 32 5 5 HELIX 2 AA2 GLN B 79 LEU B 83 5 5 HELIX 3 AA3 ARG A 53 ASN A 57 5 5 HELIX 4 AA4 SER G 349 TRP G 353 5 5 HELIX 5 AA5 ASP G 364 ASN G 370 1 7 HELIX 6 AA6 ASP G 405 ILE G 410 5 6 HELIX 7 AA7 GLY G 416 ASN G 422 1 7 SHEET 1 AA1 4 LEU L 4 SER L 7 0 SHEET 2 AA1 4 ILE L 19 VAL L 29 -1 O SER L 24 N THR L 5 SHEET 3 AA1 4 GLY L 67 ILE L 74 -1 O LEU L 72 N LEU L 21 SHEET 4 AA1 4 PHE L 61 GLY L 65 -1 N SER L 62 O THR L 73 SHEET 1 AA2 2 ILE L 10 ALA L 13 0 SHEET 2 AA2 2 LYS L 100 ILE L 103 1 O LYS L 100 N MET L 11 SHEET 1 AA3 4 ASN L 52 LEU L 53 0 SHEET 2 AA3 4 LYS L 44 TYR L 48 -1 N TYR L 48 O ASN L 52 SHEET 3 AA3 4 HIS L 33 GLN L 37 -1 N TRP L 34 O ILE L 47 SHEET 4 AA3 4 TYR L 84 HIS L 88 -1 O TYR L 86 N TYR L 35 SHEET 1 AA4 4 MET H 3 GLU H 6 0 SHEET 2 AA4 4 SER H 17 SER H 25 -1 O SER H 25 N MET H 3 SHEET 3 AA4 4 THR H 78 SER H 84 -1 O LEU H 83 N LEU H 18 SHEET 4 AA4 4 THR H 69 ASP H 73 -1 N SER H 71 O TYR H 80 SHEET 1 AA5 6 VAL H 11 VAL H 12 0 SHEET 2 AA5 6 THR H 115 VAL H 119 1 O THR H 118 N VAL H 12 SHEET 3 AA5 6 ALA H 92 ARG H 98 -1 N ALA H 92 O VAL H 117 SHEET 4 AA5 6 MET H 34 THR H 40 -1 N ILE H 37 O TYR H 95 SHEET 5 AA5 6 SER H 44 ILE H 51 -1 O ILE H 51 N MET H 34 SHEET 6 AA5 6 THR H 58 TYR H 59 -1 O TYR H 59 N ALA H 50 SHEET 1 AA6 4 VAL H 11 VAL H 12 0 SHEET 2 AA6 4 THR H 115 VAL H 119 1 O THR H 118 N VAL H 12 SHEET 3 AA6 4 ALA H 92 ARG H 98 -1 N ALA H 92 O VAL H 117 SHEET 4 AA6 4 TYR H 110 TRP H 111 -1 O TYR H 110 N ARG H 98 SHEET 1 AA7 4 MET B 4 THR B 5 0 SHEET 2 AA7 4 ARG B 18 ALA B 25 -1 O LYS B 24 N THR B 5 SHEET 3 AA7 4 ASP B 70 SER B 76 -1 O LEU B 73 N ILE B 21 SHEET 4 AA7 4 THR B 63 SER B 65 -1 N THR B 63 O THR B 74 SHEET 1 AA8 6 PHE B 10 SER B 12 0 SHEET 2 AA8 6 THR B 102 GLU B 105 1 O LYS B 103 N MET B 11 SHEET 3 AA8 6 ASP B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA8 6 VAL B 33 GLN B 38 -1 N TYR B 36 O PHE B 87 SHEET 5 AA8 6 LYS B 45 TYR B 49 -1 O MET B 47 N TRP B 35 SHEET 6 AA8 6 ASN B 53 ARG B 54 -1 O ASN B 53 N TYR B 49 SHEET 1 AA9 4 LYS A 3 GLU A 6 0 SHEET 2 AA9 4 SER A 17 SER A 25 -1 O ALA A 23 N GLU A 5 SHEET 3 AA9 4 SER A 80 ASN A 86 -1 O VAL A 81 N CYS A 22 SHEET 4 AA9 4 PHE A 70 ASP A 75 -1 N SER A 73 O TYR A 82 SHEET 1 AB1 5 GLY A 10 VAL A 12 0 SHEET 2 AB1 5 SER A 114 VAL A 117 1 O THR A 116 N VAL A 12 SHEET 3 AB1 5 GLY A 94 CYS A 98 -1 N GLY A 94 O VAL A 115 SHEET 4 AB1 5 MET A 34 SER A 40 -1 N VAL A 37 O TYR A 97 SHEET 5 AB1 5 GLY A 44 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 1 AB2 5 ASN G 354 ILE G 358 0 SHEET 2 AB2 5 ASN G 394 ARG G 403 -1 O VAL G 395 N ILE G 358 SHEET 3 AB2 5 PRO G 507 GLU G 516 -1 O SER G 514 N TYR G 396 SHEET 4 AB2 5 GLY G 431 ASN G 437 -1 N ILE G 434 O VAL G 511 SHEET 5 AB2 5 THR G 376 CYS G 379 -1 N LYS G 378 O VAL G 433 SHEET 1 AB3 2 LEU G 452 ARG G 454 0 SHEET 2 AB3 2 LEU G 492 SER G 494 -1 O GLN G 493 N TYR G 453 SSBOND 1 CYS L 23 CYS L 87 1555 1555 2.03 SSBOND 2 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 3 CYS B 23 CYS B 88 1555 1555 2.03 SSBOND 4 CYS A 22 CYS A 98 1555 1555 2.03 SSBOND 5 CYS G 336 CYS G 361 1555 1555 2.03 SSBOND 6 CYS G 379 CYS G 432 1555 1555 2.03 SSBOND 7 CYS G 391 CYS G 525 1555 1555 2.03 SSBOND 8 CYS G 480 CYS G 488 1555 1555 2.03 LINK ND2 ASN G 343 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 CISPEP 1 SER L 7 PRO L 8 0 -11.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000